Facebook
X
LinkedIn
Forward
Title |
Credit | Series date | Member price | Non-member price |
|---|---|---|---|---|
|
Leucovorin in Autism: An Evidence-Based and Clinically Informed Approach 1.25 NAPNAP Contact Hours of which 1.25 contains pharmacology content. This continuing education activity is offered free for NAPNAP Members and non-members. This presentation synthesizes the evidence on folinic acid in autism, with an emphasis on advances since 2018 within the context of foundational work. We will examine the pathophysiology of cerebral folate deficiency (CFD), clarify genetic contributors (e.g., FOLR1 and folate-pathway variants), and review clinical testing with folate receptor-α autoantibodies and related labs. Practical treatment guidance will cover formulation selection, dosing and titration, monitoring, adverse effects, and pharmacy/compounding and cost considerations. Taught by a clinician with extensive real-world experience, the presentation highlights where the evidence is strongest and how to implement it. Learners will finish with a concise, evidence-based framework for evaluating and managing CFD in autism within standard practice. |
|
11/12/2025 to 11/30/2027 | $0.00 | $0.00 |
|
Legacy Mapping: Charting Your Course to Meaningful Career This continuing education activity is a recorded presentation for NAPNAP's 2026 National Conference. Legacy mapping is a strategic framework that helps NPs align their professional goals with personal fulfillment by integrating self-reflection, mentorship and planning. This presentation offers tools and exercises to create personalized career roadmaps that foster growth, prevent burnout and enhance job satisfaction. The course will award 1.00 contact hours and is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members, and $20 for non-members. |
|
07/01/2026 to 06/30/2028 | $10.00 | $20.00 |
|
Learning Disorders 1.25 NAPNAP Contact Hour. This continuing education activity is part of NAPNAP Cares. The continuing education activity fee for non-members is $25. This course will discuss the evaluation, diagnostic decision making, and initial- and ongoing- management of learning disorders. This continuing education was reviewed and updated in 2025 to ensure compliance with current clinical standards, updated instructional content and best practices in health care education. |
|
06/12/2023 to 06/30/2027 | $12.50 | $25.00 |
|
Keeping Current in Atopic Diseases 1.25 NAPNAP Contact Hour of which 1.25 pharmacology content. This continuing education activity is offered as part of the 2025 Pediatric Pharmacology Bundle. This course is a recorded presentation for NAPNAP's 20255 National Conference. The field of Allergy & Immunology continues to expand and incorporate new therapeutics to manage difficult diseases. In 2024, new drugs have been approved that can revolutionize treatment for disease management. Patients will look to their primary care clinicians to be knowledgeable and a resource for these therapeutics. This panel will include three NP experts from food allergy centers at the Children’s Hospital of Philadelphia and University of Texas Southwestern and will discuss biologics, immunotherapy options and non-IgE mediated disease updates for food allergy. NAPNAP’s Asthma and Allergy SIG is pleased to support this session. |
|
08/29/2025 to 08/31/2027 | $0.00 | $0.00 |
|
JPHC CE: Use of Atypical Antipsychotics in Pediatric Populations 1.75 NAPNAP contact hour of which 1.75 contain pharmacology content (Rx). This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Atypical antipsychotic medications have served as mainstays in the treatment of pediatric-onset bipolar disorder and schizophrenia and are typically prescribed by psychiatric providers. These medications also have an important role in treating specific behaviors associated with other pediatric diagnoses, including autism spec-trum disorder, disruptive behavior disorders, and tic disorders. Nurse practitioners play an important role in initiating treatment in children who require these drugs and monitoring those who are already prescribed these medications by psychiatric professionals. The pharmacokinetics, pharmacodynamics, and pharmacogenomic implications for aripiprazole, olanzapine, quetiapine, and risperidone are described. This article reviews appropriate approaches to prescribing, monitoring for efficacy and side effects, and considerations when tapering or discontinuing antipsychotic medications. J pediatr Health Care. (2026) 40, 464−474. |
|
05/01/2026 to 06/30/2027 | $0.00 | $10.00 |
|
JPHC CE: Trauma Exposure in Migrant Children: Implications for Mental and Physical Health 1.5 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Global migration is a public health crisis of epidemic proportions. Migrants are at risk for a variety of physical and mental health concerns, while having limited access to healthcare. Migrant children are especially vulnerable to experiencing significant trauma, both physical and emotional. Children comprise less than one third of the global population, yet nearly half of migrants are children less than 18 years of age. The United States is home to a significant number of migrant children. Migrant children have a unique set of educational, health, and emotional needs. Given the sheer number of migrant children living in the U.S., pediatric nurse practitioners (PNP) must understand their unique needs and provide evidence-based interventions to help meet these needs. This continuing education article will discuss migrant children in terms of understanding migration, trauma exposure and resultant impact on psychological and physical health, and implications for practice. J Pediatr Health Care (2025) 40, 1-12. |
|
09/01/2025 to 10/31/2026 | $0.00 | $10.00 |
|
JPHC CE: The Landscape of Substance Use in Youth-2024 1.0 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. An essential role of pediatric providers is to counsel youth and parents on behavioral health issues, including the use of Alcohol or other drugs (AODs). Although substance use by adolescents has decreased, a significant number of adolescents use AODs, causing those with regular use to be at risk of developing behavioral, physical, and mental health consequences that can continue into adulthood. This article was written to help pediatric providers understand the scope and associated effects of AOD use in their adolescent patients and equip them to counsel, identify, and intervene to reduce the harm to their patients who use AODs. J Pediatr Health Care (2025) Issue 6, p1-12. |
|
11/01/2025 to 12/31/2026 | $0.00 | $10.00 |
|
JPHC CE: Sexting and Sextortion in Adolescents: Essentials for the PNP 1.0 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Sexting and sextortion are increasingly common concerns among adolescents, presenting significant challenges for pediatric nurse practitioners (PNPs). Sexting, or digital sharing of self-produced nude or otherwise sexual images, is increasingly seen as a normative part of adolescent sexual exploration, but carries substantial risks, particularly when images are shared non-consensually, by minors, or used as a method of bullying or extortion (“sextortion”). PNPs play a critical role in early identification of any nonconsensual texting and by providing education to adolescents so they may explore their sexuality safely, resist peer pressure, and maintain boundaries. J Pediatr Health Care (2026) 40, Issue 1, P162-173. |
|
01/01/2026 to 02/28/2027 | $0.00 | $10.00 |
|
JPHC CE: Recognition and Management of Pediatric Dental Trauma and Infections 1.0 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Dental emergencies are common during childhood and typically occur due to trauma or infection. The current evidence on managing dental injuries is from a dental perspective, with limited information on treating pediatric dental injuries in medical settings. Proper treatment of infection, correct storage, prompt repositioning, and replantation are essential for successful outcomes, as supported by the latest evidence-based guidelines. Pediatric patients have a better prognosis when proper treatment is provided without delay. Understanding potential issues enables providers to assess the severity of the condition, offer initial guidance and management, and recommend appropriate follow-up dental care. This continuing education activity aims to educate providers on how to care for children with low-acuity dental injuries and infections using an evidence-based approach. J pediatr Health Care. (2026) 40, 451-463. |
|
05/01/2026 to 06/30/2027 | $0.00 | $10.00 |
|
JPHC CE: Patellofemoral Pain Syndrome in Adolescents: Continuing Education for the Primary Care Provider 1.0 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Patellofemoral Pain Syndrome (PFPS) is a multifactorial complaint of anterior knee pain. Patellofemoral pain typically spreads diffusely across the knee, is notable during weight bearing, and is exacerbated by knee flexion. Patellofemoral pain is often insidious in onset, typically with no identifiable mechanism of injury. Factors believed to contribute to PFPS include overuse, muscular imbalance, joint malalignment, and, rarely, trauma to the joint (Bump & Lewis, 2023). J Pediatr Health Care (2025) 39, 686-694. |
|
07/01/2025 to 08/31/2026 | $0.00 | $10.00 |
|
JPHC CE: Monitoring Vaccine Safety: United States Vaccine Safety Surveillance Systems 1.0 NAPNAP contact hour of which contain 1.0 pharmacology content. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Immunization is an effective public health tool to protect children from hospitalization and death from vaccine-preventable diseases. Vaccine safety monitoring is essential to understand risks of vaccination. The Centers for Disease Control and Prevention closely monitors vaccine safety through multiple surveillance systems, including V-safe, the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. This paper briefly discusses each surveillance system and available evidence that healthcare providers can use to respond to common vaccine concerns. As trusted sources of information about vaccines, pediatric nurses and nurse practitioners need to understand how vaccine safety is monitored, where to access reliable resources about vaccines, and when and where to report adverse events noted after vaccination. J Pediatr Health Care (2026) 40, Issue 1, P174-186. |
|
01/01/2026 to 02/28/2027 | $0.00 | $10.00 |
|
JPHC CE: Improving the Healthcare Experience Through Improved Communication for Individuals with Autism Across the Spectrum: A Tutorial 0.75 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Individuals with autism experience many barriers to receiving high quality healthcare. With 1 in 31 children now being diagnosed with autism, a number that has only been increasing over the last decade, it is imperative to address these barriers. One of the most prevalent barriers is communication. Social communication challenges are a defining characteristic of autism, but there exists a wide spectrum of communication abilities that can be difficult for healthcare providers to understand. This tutorial introduces the differences in informational processing experienced by those with autism with practical guidance on how healthcare providers can individualize their approach to communication when providing patient-centered care. The three levels of autism support are used as a framework, with suggestions specific to each level to help healthcare providers better understand the differences seen in autism and how they can more readily address the needs of each patient. J pediatr Health Care. (2026) 40, 608-616. |
|
07/01/2026 to 08/31/2027 | $0.00 | $10.00 |
|
JPHC CE: Child Maltreatment Consequences: Essentials for Pediatric Nurse Practitioners 1.5 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Child maltreatment is a global pediatric healthcare problem of epidemic proportions. Child maltreatment negatively impacts short and long-term physical, mental, and social health outcomes for child victims. It is imperative that PNPs possess an understanding of the consequences related to experiencing child maltreatment and implement evidence-based interventions to foster healing. This continuing education article will discuss the consequences of child maltreatment and suggest implications for PNP practice including anticipatory guidance, screening, and evidence-based interventions using a trauma-informed approach for child victims. J pediatr Health Care. (2026) 40, 617-629. |
|
07/01/2026 to 08/31/2027 | $0.00 | $10.00 |
|
Itching, Sneezing, Coughing, Wheezing- New Pharmacology for the troublesome symptoms of Pediatric Allergy! 1.00 NAPNAP contact hour of which 1.00 pharmacology content. This continuing education activity is offered as part of the Pediatric Pharmacology Bundle. This course is a record presentation for NAPNAP's 2026 National Conference. This lively review of pediatric allergy will discuss the newest medications for anaphylaxis, allergic rhinitis, atopic dermatitis and asthma. We will explore the newest immunotherapy treatments as they enhance desensitization. |
|
07/01/2026 to 06/30/2028 | $0.00 | $0.00 |
|
Intellectual disability 2.0 NAPNAP Contact Hour, including 0.25 Pharmacology and 0.25 Psychopharmacology hours. This continuing education activity is part of NAPNAP Cares and is offered at a reduced rate to NAPNAP members. This continuing education activity rate is $20 for NAPNAP members. For non-members, this continuing education activity rate is $40. This course will discuss the evaluation, diagnostic decision making, and initial- and ongoing- management of Intellectual disability. This continuing education activity was reviewed in 2025 to ensure compliance with current clinical standards, updated instructional content and best practices in health care education. |
|
12/08/2023 to 12/31/2027 | $20.00 | $40.00 |